Clinical Trial: Comparing the Efficacy and Safety of Chemotherapy Combined With or Without Immunotherapy as an Adjuvant Treatment After Radical Surgery for Patients With Resectable Adenocarcinoma of the Esophagogastric Junction of Gastric Cancer

U.S., Aug. 21 -- ClinicalTrials.gov registry received information related to the study (NCT07132528) titled 'Comparing the Efficacy and Safety of Chemotherapy Combined With or Without Immunotherapy as an Adjuvant Treatment After Radical Surgery for Patients With Resectable Adenocarcinoma of the Esophagogastric Junction of Gastric Cancer' on Aug. 10.

Brief Summary: This study is to evaluate the efficacy and safety of chemotherapy combined with or without Immunotherapy as an Adjuvant Treatment After Radical Surgery for Patients With Resectable Adenocarcinoma of the Esophagogastric Junction of Gastric Cancer

Study Start Date: Aug. 31

Study Type: INTERVENTIONAL

Condition: Gastric / Gastroesophageal Junction Adenocarcinoma

Intervention: D...